Brief Summary
Type:
Lymphomas
Study Type:
Treatment
Phase:
II
ClinicalTrials.gov Identifier:
NCT05633615
Study #:
STUDY00160232
Start Date:
Mar 24, 2024
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT05633615
View Complete Trial Details & Eligibility at ClinicalTrials.gov
